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Abstract
Recently, scaffolds for tissue regeneration purposes have been observed to utilize nanoscale
features in an effort to reap the cellular benefits of scaffold features resembling extracellular
matrix (ECM) components. However, one complication surrounding electrospun nanofibers is
limited cellular infiltration. One method to ameliorate this negative effect is by incorporating
nanofibers into microfibrous scaffolds. This study shows that it is feasible to fabricate
electrospun scaffolds containing two differently scaled fibers interspersed evenly throughout
the entire construct as well as scaffolds containing fibers composed of two discrete materials,
specifically fibrin and poly(ε-caprolactone). In order to accomplish this, multiscale fibrous
scaffolds of different compositions were generated using a dual extrusion electrospinning
setup with a rotating mandrel. These scaffolds were then characterized for fiber diameter,
porosity and pore size and seeded with human mesenchymal stem cells to assess the influence
of scaffold architecture and composition on cellular responses as determined by cellularity,
histology and glycosaminoglycan (GAG) content. Analysis revealed that nanofibers within a
microfiber mesh function to maintain scaffold cellularity under serum-free conditions as well
as aid the deposition of GAGs. This supports the hypothesis that scaffolds with constituents
more closely resembling native ECM components may be beneficial for cartilage regeneration.
(Some figures may appear in colour only in the online journal)
1. Introduction
Fibrous scaffolds are commonly used in tissue engineering
due to their characteristic high porosities and interconnected
pores, which have been shown to facilitate cellular infiltration
and homogenous tissue regeneration [1–3]. Previous reports
have indicated that the size scale of the fibers in such a
4 Authors to whom any correspondence should be addressed.
scaffold can have a significant effect on tissue development.
Specifically, nanoscale features are desired because they more
closely resemble components of a native extracellular matrix
(ECM) such as collagen fibers [4–6]. However, it is also fairly
well accepted that high concentrations of nanoscale fibers often
lead to increased cell spreading and limited cellular infiltration
[7, 8]. For this reason, the logical progression is to fabricate
scaffolds that combine microfibers with nanofibers, in an effort
to maintain larger pore sizes, while harnessing the positive
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Figure 1. Dual extrusion electrospinning with a rotating mandrel diagram.
effects of nanofibers, such as increased cellular attachment
as well as improved differentiation and ECM production
[9]. While previous efforts have combined nanofibers with
microfibers to form multiscale scaffolds in a layer-by-layer
electrospinning approach or by combining electrospinning
with three-dimensional melt deposition, few efforts report the
fabrication of a completely electrospun multiscale scaffold
generated by continuous means with a relatively homogenous
distribution of micro and nanofibers throughout the entire
scaffold [7, 8, 10–13]. Soliman et al describe a method
whereby multiscale scaffolds are formed by dual extrusion of
fibers onto a flat stage pivoting orthogonally to the collection
surface to facilitate fiber mixing [14]. An alternative fiber
mixing strategy is demonstrated in this work in which a
cylindrical rotating mandrel is used to collect the electrospun
fibers.
With the notion of creating scaffolds of varied internal
structures or size scales comes the concept of altering the
material composition in an effort to exact a more favorable
cellular response. As in any field of tissue engineering,
both natural and synthetic materials are being explored
for generating engineered cartilage. Natural biomaterials for
cartilage engineering tend to be either protein, such as collagen
and fibrin [15–18], or polysaccharide based, such as alginate
and chitosan [19–24]. The benefit of using natural materials
is that they innately support cell attachment and proliferation
and are generally biodegradable. Alternatively, the properties
of synthetic materials are easily reproducible and tunable
with known degradation rates and low immunogenicity. A
scaffold which is able to combine fibers of a synthetic
polymer to harness its reproducible properties with some
fibers of a natural composition to improve cellular responses
could be quite advantageous. Recently, it was confirmed that
fibrin may be electrospun into nanofibrous structures [25].
This offers a unique opportunity to generate a completely
electrospun composite fibrous scaffold by uninterrupted
methods containing differently scaled fibers composed of
two separate materials, specifically, a highly bioactive natural
material such as fibrin and a synthetic material such as
poly(ε-caprolactone) (PCL).
The objective of this study was to demonstrate the
feasibility of fabricating electrospun scaffolds consisting of
two differently scaled fibers interspersed evenly throughout
an entire construct as well as scaffolds containing fibers
composed of two individual materials, specifically fibrin and
PCL. These different scaffold types were then characterized
and examined to determine whether the presence of nanofibers,
either synthetic or natural, within a mesh of microfibers
had any effect on cellularity and glycosaminoglycan (GAG)
deposition over scaffolds composed solely of microfibers.
It was hypothesized that scaffolds containing bioactive
nanofibers composed of fibrin would lead to improved
cellular proliferation, distribution and GAG production when
compared to scaffolds composed entirely of PCL regardless of
scaffold architecture.
2. Methods
2.1. Electrospinning
Scaffolds containing PCL microfibers (Pμ), PCL microfibers
with PCL nanofibers (PμPn), and PCL microfibers and fibrin
nanofibers (PμFn) were electrospun using a dual extrusion
process with a rotating mandrel to ensure thorough mixing of
the two fiber types (figure 1). The mandrel (∅ = 4.8 cm) was
set to rotate at a maximum speed of 120 RPM to facilitate fiber
mixing without resulting in aligned fibers. Microfibers were
fabricated using a 35% (w/v) PCL (MW = 43 000–50 000,
Polysciences, Warrington, PA) solution in a 5:1 (v/v) ratio
of chloroform: methanol extruded at a rate of 8 mL h−1 with
7 kV applied voltage. Prior to electrospinning, fibrinogen was
isolated from human plasma by cryoprecipitation as previously
described [25, 26]. Fibrin nanofibers were generated using
previously described methods [25]. Specifically, 50 mg
mL−1 fibrinogen in 6% (w/v) poly(vinyl alcohol) (PVA) and
300 U thrombin (Merck, Darmstadt, Germany) in 8% (w/v)
PVA with 10 mM calcium chloride were co-extruded from
separate syringes through a mixing applicator tip at a rate of
0.4 mL h−1 with an applied voltage of 18 kV. PCL nanofibers
were fabricated using a 32% (w/v) PCL solution in formic acid
extruded at a rate of 0.1 mL h−1 with a 13 kV applied voltage.
Prior to sterilization for cell seeding, meshes containing PCL
nanofibers were washed thoroughly with phosphate buffered
saline (PBS) and air dried for one day to remove any residual
formic acid.
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2.2. Scaffold morphology
Electrospun scaffolds were mounted on aluminum stubs and
sputter-coated with 20 nm of gold prior to imaging with a
scanning electron microscope (SEM) (FEI Quanta 400 ESEM
FEG, FEI Co, Hillsboro, OR). The average microfiber diameter
for each scaffold type was determined from six separate SEM
images taken at 1000 × magnification from three random
locations on the electrospun mat. On each SEM image, the
diameter of five fibers was measured using the manufacturer
supplied software for a total of 30 discrete measurements per
scaffold type. Nanofibers were measured from SEM images
of three random locations on the electrospun mat taken at
15 000 × with ten fibers measured per location for a total
of 30 separate measurements. Furthermore, two discs (∅ =
6 mm) from different locations on each type of fibrous mat
generated were taken and prepared for SEM imaging of a
scaffold vertical cross-section. To accomplish this, each die
cut scaffold was submerged in liquid nitrogen for 1 min to aid
in achieving a clean vertical cross-section. After the scaffolds
were thoroughly frozen, they were sectioned perpendicular
to the scaffold face into thin slices using a microtome blade,
mounted on aluminum stubs, sputter-coated, and imaged via
SEM.
2.3. Scaffold porosity
The porosity and pore size of the electrospun meshes were
determined via mercury intrusion porosimetry. First, the bulk
volume and weight of each scaffold were measured. Scaffolds
were then placed individually in a mercury porosimeter
(Quantachrome Instruments, Boynton Beach, FL) which
forced mercury through the pores of the scaffolds (n = 3)
ultimately reaching a final pressure of 50 psi. For the contact
angle between PCL and mercury in air, an angle of 140◦ was
used as reported in previous work [7]. The porosity (ε) was
then calculated as
ε = Vpore
Vpore + 1/ρ × 100%,
in which the pore volume (Vpore) was estimated as the
volume of intruded mercury per gram of scaffold and ρ is
the density of PCL. The pore size was computed from the
volume versus pressure data using the manufacturer supplied
software (Quantachrome Poremaster for Windows, version
8). For mercury porosimetry calculations regarding the PμFn
scaffolds, it was assumed that the effect of fibrin on the bulk
material density was negligible. Thus for these scaffolds the
bulk material density was assumed to be equal to that of PCL
alone.
2.4. Cell isolation and expansion
Human mesenchymal stem cells (hMSCs) were isolated
from umbilical cord blood using a Ficoll-Paque gradient
(Amersham-Pharmacia), plastic adherence selection and flow
cytometry verification of the MSC phenotype as previously
described [25]. Specifically, the cell population isolated with
flow cytometry displayed positive expression of surface
markers CD29, CD44, CD73 and CD90 and negative
expression of markers CD31, CD33, CD34 and CD45 which
are often used to indicate the MSC phenotype [27–30].
Similarly sourced cells have been previously shown
to successfully differentiate toward the osteoblastic and
chondrocytic lineages [29–32]. After isolation, cells were
expanded in general growth medium containing Iscove’s
Modified Dulbecco’s Medium (Gibco), 10% MSC-qualified
fetal bovine serum (FBS) (Gibco), 10% general FBS (Gibco),
as well as 1% penicillin–streptomycin.
2.5. Cell seeding and culture
Electrospun scaffolds were die cut into discs of 6.2 mm in
diameter and ethylene oxide sterilized. Only scaffolds 0.4–
0.6 mm thick were used for cell studies. Prior to seeding,
scaffolds were sterilely pre-wet using a decreasing ethanol
gradient (90–35%), rinsed with sterile water and centrifuged,
and then incubated in general growth medium overnight.
The pre-wet scaffolds were then pressfit into 96 well plates
and seeded with 75 000 passage 6 hMSCs per scaffold.
Seeded scaffolds were then incubated for a 3 h pre-attachment
period. After the pre-attachment period, the wells were filled
with chondrogenic medium containing Dulbecco’s Modified
Eagle’s Medium (Gibco), 1% ITS+ premix (BD Biosciences),
50 mg L−1 ascorbic acid, 10−7 M dexamethasone and 0.4 mM
L-proline, and incubated for the remaining 24 h attachment
period. Day 0 samples were prepared for analysis after the 3 h
pre-attachment period. After the 24 h attachment period, the
scaffolds were unconfined from the 96 well plates and placed
in 24 well plates with chondrogenic medium for the duration
of the study. Medium was changed every three days. Samples
were taken at days 0, 7, 14, and 21, washed with PBS 3 × ,
and prepared for analysis.
2.6. Construct imaging
For visualization via SEM, cultured constructs were fixed by
incubating with 2% glutaraldehyde for 1 h. Samples were then
dehydrated using an increasing ethanol gradient (30–90%) and
dried. The samples (n = 2) were then sputter-coated with 20 nm
gold and imaged using SEM (JSM-6490LA, Tokyo, Japan) to
visualize cell spreading and ECM production on the surface
of the different scaffold types.
In preparation for confocal imaging, samples (n = 2) were
fixed in 4% paraformaldehyde for 20 min and then rinsed with
PBS. Cell membranes were permeabilized with 0.5% Triton
X-100 in PBS for 10 min and then washed with 1% FBS
and PBS to minimize background staining. Finally, the cells
were stained for F-actin with 1:1000 Texas Red-X phalloidin
(molecular probes) in PBS for 1 h. Samples were rinsed
with PBS to remove any unconjugated probes. The stained
scaffolds were imaged at 594 and 488 nm wavelengths and
20 × magnification using a confocal microscope (Leica TCS
SP5 II). In addition to composite z-stack images, image slices
were viewed separately in succession to examine individual
cellular morphologies.
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2.7. Histology
At each time point, samples (n = 2) were fixed in 10%
buffered paraformaldehyde overnight at 4 ◦C. Scaffolds were
then dehydrated using an increasing ethanol gradient (30–
90%) and stored in 100% isopropanol at 4 ◦C. Prior to
sectioning, samples were embedded in HistoPrep frozen tissue
embedding medium (Fisher Scientific, Pittsburgh, PA). A
cryotome (CM1850, Leica Microsystems, Bannockburn, IL)
was used to cut sections 8 μm thick which were then mounted
on glass slides and incubated on a slide warmer at 45 ◦C for a
minimum of five days.
To visualize the cartilage-like ECM produced, sections
were rehydrated with water and then stained with 0.1%
Safranin O for 5 min. The slides were then rinsed with
water and air dried. Stained sections were imaged with a
light microscope (Zeiss AxioImager.Z2, Go¨ttingen, Germany)
using a peripheral camera (AxioCam MRc 5, Zeiss, Go¨ttingen,
Germany) and computer. Automatic exposure and white
balance correction were applied to the captured images using
the manufacturer supplied software (AxioVision 4.8, Zeiss,
Go¨ttingen, Germany).
In order to visualize cellular infiltration of the different
scaffold architectures, sections were also stained with Fast
Green FCF (Sigma). Sections were first washed with 1% acetic
acid and then treated with 0.02% Fast Green FCF for 3 min at
which point the slides were then rinsed with 1% acetic acid.
The stained sections were imaged using a light microscope
with automatic exposure and white balance correction applied
using the manufacturer supplied software.
2.8. Biochemical assays
In an effort to determine the cellularity and GAG content of
the scaffolds at the various time points, samples (n = 4) were
initially placed in 0.5 mL of water and frozen at −80 ◦C. The
samples were then treated with three freeze/thaw/sonicate
cycles resulting in a cell lysate. The DNA content of the cell
lysate was then quantified using the fluorometric PicoGreen
assay kit (Molecular Probes, Eugene, OR) with an excitation
wavelength of 490 nm and an emission wavelength of 520 nm.
The dsDNA standards and samples were run side by side in
triplicate to calculate the DNA content per scaffold.
Prior to quantifying GAG content, scaffolds were
removed from the cell lysate used in determining DNA
content and digested at 56 ◦C in 0.5 mL of proteinase K
(1 mg mL−1 proteinase K, 185 μg mL−1 iodacetamide and
10 μg mL−1 pepstatin A in Tris/EDTA buffer containing
6.055 mg mL−1 tris(hydroxymethyl aminomethane and 372 μg
mL−1 EDTA at pH 7.6). GAG content was then quantified
using the 1,9-dimethymethylene blue (DMMB) assay and
measured at 520 nm using a microplate reader (BIO-TEK
Instrument, Winooski, VT). Chondroitin sulfate standards, cell
lysate samples and proteinase K digest samples were all run
in duplicate and then averaged to adjust for any experimental
error. GAG concentrations determined from the cell lysate and
proteinase K digest for each individual sample were summed
to determine the final GAG content for each sample.
Table 1. Scaffold characteristics including average micro and
nanofiber diameters, porosity and pore size. Within a particular
characteristic, a scaffold type which is determined to be statistically
different from both of the other scaffold types is indicated by an
asterisk, ‘∗’ (p < 0.05).
Characteristic Pμ PμPn PμFn
Microfiber 10.1 ± 1.1 9.8 ± 1.4 8.8 ± 1.1∗
diameter (μm)
Nanofiber 0 ± 0∗ 194.6 ± 45.9∗ 250.0 ± 50.2∗
diameter (nm)
Porosity (%) 86.5 ± 0.4∗ 91.8 ± 1.7 90.0 ± 0.7
Pore size (μm) 32.8 ± 0.1∗ 13.4 ± 2.5∗ 28.1 ± 1.3∗
2.9. Statistical methods
Scaffold characteristics and biochemical assay results are
reported as means ± standard deviation. A one-way ANOVA
was performed to evaluate significant differences (p < 0.05)
in fiber diameter, porosity and pore size. A two-way ANOVA
was performed to evaluate significant differences (p < 0.05) in
construct cellularity and ECM content. If significant difference
was determined, the Tukey’s HSD test was performed to make
multiple comparisons between groups.
3. Results
3.1. Scaffold characterization
SEM images of the different scaffold types demonstrated that
it was possible to fabricate electrospun mats using continuous
methods to create scaffolds of two different fiber scales as
well as two different materials (figure 2). Images of vertical
scaffold cross-sections taken using SEM revealed that when
nanofibers were incorporated into a microfiber mesh using
the dual extrusion electrospinning process with a rotating
mandrel, nanofibers were truly interspersed throughout the
entire construct (figures 2(g)–(i)). These images also showed
that, with respect to volume, the nanofiber containing scaffolds
were composed of more microfibers than nanofibers due to
the much lower polymer extrusion rates necessary to produce
nanofibers compared to microfibers. The scaffolds that were
generated consisted of fairly similarly sized microfibers with
averages between 8.8 and 10.1 μm. It is important to note,
however, that the PμFn scaffold fiber diameter (8.8 ±
1.1 μm) was significantly lower than the other two scaffold
types (table 1). Despite having a smaller average microfiber
diameter, the PμFn scaffolds still displayed porosities similar
to PμPn scaffolds as well as significantly higher porosities than
microfibers alone. Examining the nanofibers in the PμPn and
PμFn scaffolds, it was observed that nanofibers, regardless of
composition, exhibited diameters that were primarily less than
400 nm when using these methods of fabrication. Furthermore,
it was evident that the PμPn scaffolds contained a higher
density of nanofibers than the PμFn scaffolds due to the
different extrusion rates necessary to stably electrospin the
differently composed nanofibers.
Porosity as determined by mercury intrusion
demonstrated that the scaffolds exhibited reasonably
high porosities even with the incorporation of nanofibers.
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(a) (b) (c)
(d) (e) (f )
(g) (h) (i)
Figure 2. Scanning electron micrograph images of the different electrospun scaffold architectures and compositions that were generated:
(a), (d) Pμ, (b), (e) PμPn, (c), ( f ) PμFn. Vertical cross-sections of the different scaffolds show the distribution of nanofibers with respect to
microfibers throughout the thickness of the scaffold: (g) Pμ, (h) PμPn, (i) PμFn.
In fact, the Pμ scaffolds had a significantly lower porosity
than the other two scaffold groups which featured nanofibers.
Despite displaying a lower porosity than the other two scaffold
types, the Pμ scaffolds bore significantly larger pore sizes
than the scaffolds containing nanofibers. Additionally, the
PμPn scaffolds, which had the highest density of nanofibers
as seen in SEM images, exhibited the smallest average pore
size of all of the scaffold types.
3.2. Construct imaging
From confocal images, it was seen that after only 3 h, cell
spreading was evident on all three scaffold types (figure 3).
However, on the PμPn scaffolds cells appeared to display a
flattened, broad polygonal morphology, while cells on the Pμ
and PμFn scaffolds exhibited more elongated and spindle-like
morphologies, as indicated with arrows included in figure 3.
Likewise, hMSCs on the PμPn scaffolds displayed a different
pattern of cell localization as compared to the other two
scaffold types. In this case, cells on Pμ and PμFn scaffolds
were primarily attached and spread along microfibers, while
the cells on the PμPn scaffolds appeared to span the area
between the microfibers more often than on the other two
scaffold types.
Scanning electron micrographs revealed that throughout
the entire culture period cells and ECM appeared denser on
the surface of scaffolds containing PCL nanofibers (figure 4).
Similarly, early in the culture duration scaffolds containing
nanofibers, PμPn and PμFn, displayed more cells and ECM on
the scaffold surface. At a later culture duration, it was observed
that fewer cells and ECM were located on the surface of the Pμ
and PμFn scaffolds, while the surface of the PμPn scaffolds
was almost completely coated with cells and ECM.
3.3. Histology
In an effort to examine the production and deposition of ECM
within the different scaffolds as well as cellular infiltration,
samples from each time point were cryosectioned and stained
with either Safranin O for GAGs (figure 5) or Fast Green
for cytoplasm (figure 6). Looking at Safranin O staining,
negligible staining was seen at day 0 as expected. However
as time progressed, scaffolds containing nanofibers (PμPn
and PμFn) exhibited more deposition of GAGs than scaffolds
composed of microfibers alone (Pμ) as was seen on the day 21
histological sections in figure 5. On the PμFn scaffolds, GAG
deposits were seen deep within the interior of the scaffold
in addition to the coating on the surface. These outcomes
confirm the result of the DMMB biochemical assay for GAG
5
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(a) (b) (c)
Figure 3. Composite z-stack confocal images showing spreading and arrangement of phalloidin labeled cells highlighting F-actin (red) on
day 0 (a) Pμ (b) PμPn and (c) PμFn scaffolds (green). Arrows indicate examples of individual cell morphologies and arrangements.
(a) (b) (c)
(d ) (e) (f )
Figure 4. SEM images of constructs showing cells and ECM deposition on the surface of (a), (d) Pμ, (b), (e) PμPn, and (c), ( f ) PμFn
scaffolds on (a), (b), (c) day 7 and (d), (e), ( f ) day 21.
content. With respect to cellular infiltration as viewed by
Fast Green staining, it appeared that maximum cellular depth
was fairly similar in all three scaffold types (figure 6). In
the uppermost portion of the scaffolds, the PμPn scaffolds
displayed a more scattered distribution of cells while cells
were primarily located on the surface of the other two scaffold
types. However, while images showed a higher occurrence of
Fast Green staining in the upper half of the PμPn scaffolds, the
Pμ and PμFn scaffolds appeared to exhibit greater Fast Green
staining at the ultimate depth of infiltration than was observed
in the PμPn group.
3.4. Biochemical assays
None of the scaffold types displayed a significant increase or
decrease in total DNA content throughout time with respect to
the initial cell seeding suspension (figure 7). This demonstrated
that cell numbers remained fairly constant throughout the
duration of the study regardless of scaffold composition and
architecture.
To assess the effect of scaffold architecture on
the production of GAGs, a common cartilaginous ECM
component, by hMSCs, the DMMB biochemical assay for
sulfated GAGs was performed. At day 14, the PμFn samples
displayed significantly higher GAG contents (0.87 ± 0.2 μg
per scaffold) than both of the other scaffold types at the
various time points with exception to the PμPn samples on
day 14 (0.46 ± 0.2 μg per scaffold) (figure 8). No significant
difference was observed in GAG deposition with respect to
time for any of the three scaffold types. When GAG content
was normalized to DNA content, trends appeared similar to
those of the GAG data that was not normalized (figure 9).
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(a) (b) (c)
(d ) (e) (f )
Figure 5. Safranin O staining for GAGs of (a), (b), (c) day 0 and (d), (e), ( f ) day 21 histological sections for (a), (d) Pμ, (b), (e) PμPn, and
(c), ( f ) PμFn scaffolds. Arrows indicate regions of staining within the interior of the construct. Scale bars represent 100 μm.
(a) (b) (c)
Figure 6. Fast Green staining for cytoplasm of day 21 histological sections for (a) Pμ day 21, (b) PμPn day 21, and (c) PμFn day 21
scaffolds. Arrows indicate regions of staining within the interior of the construct. Scale bars represent 100 μm.
However, there was no statistically significant difference in
normalized GAG contents among the different scaffold types.
Similarly, there was no statistical difference in GAG/DNA
amounts with time for any scaffold type.
4. Discussion
In order for tissue engineering to progress, it is becoming
increasingly important to develop materials that function
beyond mere support structures for cells. Previous work has
shown that electrospun PCL scaffolds support the attachment
and deposition of cartilage-like ECM by chondrocytes and
MSCs possibly because the three-dimensional architecture of
electrospun PCL resembles the morphology of collagenous
ECM [5, 33]. As such, it follows that scaffolds more closely
resembling the scale and architecture of native ECM would
lead to improved cellular responses. Previous studies have
shown that scaffolds containing both micro and nanofibers
result in better cellular adhesion, viability and scaffold
infiltration as well as ECM production when compared to
single-scaled fiber controls [10, 11, 13, 14, 34]. The benefit
of multiscale fibrous scaffold generation by continuous means
as investigated here over previously described methods, such
as tandem melt deposition with electrospinning or layer-by-
layer electrospinning, is that fabrication via the dual extrusion
method with a rotating mandrel offers more reproducibility
due to fewer steps and minimized human influence on
fabrication. Also, scaffolds formed in this manner demonstrate
a homogenous distribution of micro and nanofibers throughout
the entire scaffold while other fabrication techniques often lead
to stratified compositions. While Soliman et al showed that
simultaneous dual extrusion was useful for the production of
multiscale fibrous scaffolds, methods described in the current
work demonstrate the added value of fabricating scaffolds
7
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Figure 7. Scaffold cellularity as determined by total DNA content
per scaffold. In this instance, the group indicated as ‘cells’ denotes
the DNA content of the initial cell suspension used to seed each of
the scaffold types on day 0. DNA contents are represented as
mean ± standard deviation for n = 4 samples.
Figure 8. GAG content of scaffolds at days 0, 7, 14, and 21 as
determined by the DMMB assay. GAG contents are represented as
mean ± standard deviation for n = 4 samples. Different scaffold
types marked with an asterisk, ‘∗’, indicate significant difference in
GAG content for a specific time point. Statistical significance of a
particular scaffold type at a specific culture period compared to both
of the other scaffold types at every other time point is indicated by a
‘‡’.
Figure 9. GAG content normalized by total DNA content per
scaffold at days 0, 7, 14 and 21 as determined by the DMMB assay.
Normalized GAG contents are represented as mean ± standard
deviation for n = 4 samples.
with fibers composed of different materials in an uninterrupted
fashion [14]. This additional feature increases the capacity of
this system to fine-tune the generation of a particular scaffold
for a specific application.
To examine the cellular response to nanofibers while
trying to maintain larger pore sizes for cellular infiltration,
different scaffolds were fabricated containing both micro and
nanofibers. This was accomplished by extruding polymer
solutions at different rates and applied voltages from opposite
sides of a rotating mandrel. In this manner, scaffolds containing
both micro and nanofibers as well as fibers of two different
materials, PCL and fibrin, were generated. A higher voltage
was needed to produce fibrin nanofibers in a reproducible
manner than was needed for the production of PCL nanofibers,
quite possibly due to a difference in viscosity, surface tension
and/or conductivity of the polymer solutions used. As a
result of this difference, the diameter of the microfibers
within the PμFn scaffolds was significantly lower than that
of the microfibers in the other two scaffold types. It is likely
that the change in the electric field of the whole system
was responsible for the observed slight decrease in PCL
microfiber diameter for the PμFn scaffolds compared to the
PμPn scaffolds. Images of vertical scaffold cross-sections
demonstrated that this fabrication method was successful
in generating scaffolds in which the different fiber types
were well mixed throughout the entire scaffold (figures 2(g)–
(i)). The nanofiber containing scaffolds that were generated
contained visibly different nanofiber densities with the PμPn
scaffolds exhibiting more densely packed nanofibers. As
a result, despite having comparable porosities, the PμPn
scaffolds displayed smaller pore sizes than the PμFn scaffolds.
Confocal images taken shortly after cell attachment
showed that hMSCs on scaffolds containing PCL nanofibers,
PμPn, were broad and flattened and appeared to span inter-
microfiber gaps (figure 3). Likewise, SEM and histology
images revealed that scaffolds containing PCL nanofibers
exhibited a surface densely coated with cells and ECM. This
is possibly due to the smaller pore sizes of the PμPn scaffolds
as a result of dense nanofiber packing which could partially
restrict cellular infiltration. Fast Green staining of histological
sections supports this theory, showing that while the maximum
cellular infiltration was similar for all three scaffold types,
proportionally more of the cells in the PμPn scaffolds
remained in the upper region of the scaffold. Compared to the
PμPn scaffolds, the Pμ and PμFn scaffolds appeared to exhibit
greater Fast Green staining at the ultimate depth of infiltration.
The difference in cellular infiltration patterns of the PμPn
scaffolds in comparison to the Pμ and PμFn scaffolds may be
due to the relative pore sizes of the different scaffold types.
Similarly, it is possible that the distribution of nanofibers with
respect to microfibers within the PμPn scaffolds provided a
method to assist cells in spanning inter-microfiber gaps. These
cellular bridges in turn may have resulted in the dispersion
of cells in the upper portion of the scaffold, while within this
region Pμ and PμFn scaffolds displayed cells primarily on the
scaffold surface.
Confocal images taken 3 h after initial cell attachment
revealed that hMSCs on Pμ and PμFn scaffolds
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spread maintaining an elongated, spindle-like morphology
characteristic of MSCs. On these two scaffolds, hMSCs
primarily attached along the length of microfibers as seen
in confocal and SEM images (figures 3 and 4). In contrast,
cells attached to PμPn scaffolds spread appearing broad and
flat spanning the space between microfibers. As such, the cells
spread on the nanofibers of the PμPn scaffolds resembling
two-dimensional cultures as opposed to the intended three-
dimensional scaffold environment. Furthermore, the broad
and flat hMSC morphology could potentially have an
adverse effect on tissue development within a scaffold as
previous studies have shown that a flat polygonal cell shape
sometimes precedes reduced proliferation and chondrogenic
differentiation capacity compared to more elongated cells with
spindle-like morphologies [35–37].
In a serum-free culture environment without additional
growth factors, it is not uncommon to see limited cellular
proliferation [6, 38]. Here, there was neither a significant
increase nor decrease in total DNA content of all scaffold types
over the course of 21 days. This indicated that all three scaffold
types were sufficient for supporting MSC culture. Sometimes it
is desirable to induce increased cellular proliferation as greater
cell numbers may lead to increased ECM deposition. However,
as cells proliferate metabolic resources are somewhat allocated
away from matrix production. In this fashion, when attempting
to generate ample ECM within a polymeric scaffold, it is
important to not only consider the effect of the scaffold
on cellular proliferation but also on the ECM content of
the scaffolds as culture progresses. As such in addition to
quantifying the DNA content of the different scaffold types
over time, the GAG content of the scaffolds was also measured.
From the DMMB biochemical assay, it was determined that
PCL microfibers interspersed with fibrin nanofibers exhibited
significantly higher GAG contents at day 14 than the PCL
microfiber control group. Furthermore, at day 14 the PμFn
samples contained more GAG total than both of the other
scaffold types at the various time points with exception to
the PμPn samples on day 14. These results suggest that the
presence of nanofibers, specifically fibrin nanofibers, within
the scaffold had a positive influence on the production of GAGs
by hMSCs in 14 days of culture even in the absence of growth
factors. It was hypothesized that the inclusion of nanofibers
would lead to a significant increase in GAG production
by the differentiating cells because nanoscale features more
closely resemble the components of native ECM and as such
may lead to improved cellular responses [5, 6]. However,
both the total GAG content of the scaffolds and GAG/DNA
amounts stayed relatively constant throughout the entire
culture duration. One possible explanation for this is that some
soluble GAGs produced by the cells may have diffused into the
surrounding culture medium rather than remaining within the
scaffold. Evidence of this behavior has been shown in previous
studies measuring GAG content as a diagnostic of tissue
engineered cartilage development as well as cartilage explant
culture [33, 39–41].
Histological sections exhibited increased proteoglycan
deposits with the incorporation of nanofibers within microfiber
meshes as indicated by Safranin O staining. This suggests
that the cells responded to the nanofibers in the scaffolds by
producing more ECM as compared to scaffolds composed
of microfibers alone. This evidence supports the hypothesis
that a scaffold architecture more closely resembling a native
ECM, whether it is with respect to scale or composition,
could be advantageous for cartilage-like matrix production
and deposition.
While it is difficult to make direct comparisons between
scaffolds that have been fabricated using different extrusion
rates and post-fabrication processing techniques, this work
does show that it is feasible to produce biodegradable
nonwoven fibrous meshes composed of microfibers mixed
with nanofibers throughout an entire scaffold. Also, it is
possible to produce such multiscale scaffolds containing fibers
of two discrete compositions. One of the limitations of the
electrospinning technique is that processing parameters such
as the extrusion flow rate and voltage are dependent on
the polymer solution composition. Due to the processing
limitations necessary to produce nanofibers from distinct
compositions, it is necessary to further examine the effect
extrusion rates have on scaffold characteristics and cellular
responses. Cell culture on these multiscale scaffolds has shown
that the inclusion of nanofibers does not negatively affect
cell growth or matrix production. In fact, histological images
suggest that the inclusion of nanofibers is beneficial toward the
production and distribution of GAGs. The interaction between
fiber composition, scale, porosity and pore size as related to
the development of the ECM should be more closely studied.
Future work should look to fine-tune the density of nanofibers
with respect to microfibers in an effort to harness the positive
influence of nanofibers on cellular responses, such as improved
ECM production and cell attachment, while minimizing any
negative effects such as limited infiltration.
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